Manufacturer record
Nexkem Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Nexkem Pharmaceuticals Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between June 2025 and April 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: MLS-24943, Ramipril Tablets I.P. 1.25mg (exp Sep 2026). SDT&RL, Bhubaneswar (state lab) found it not of standard quality: Content of Ramipril & Dissolution test. Listed in the April 2026 alert.
Records by type
2 records linked to Nexkem Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ramipril Tablets I.P. 1.25mg | Batch MLS-24943Mfg Oct 2025 · Exp Sep 2026 | Content of Ramipril & Dissolution testDissolution | SDT&RL, BhubaneswarState lab | Apr 2026 |
| Pantoprazole Gasrro- Resistant and Domperidone Prolonged Release Capsules IP (Prazentasure-DSR Capsules) | Batch NC24004Mfg Sep 2024 · Exp Aug 2026 | Dissolution of Pantoprazole in Buffer StageDissolution | CDL KolkataCDSCO lab | Jun 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.